PUBLISHER: TechSci Research | PRODUCT CODE: 1309874
PUBLISHER: TechSci Research | PRODUCT CODE: 1309874
Medication Adherence Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented Type, By Medication, By Region, and Competition
We offer 8 hour analyst time for an additional research. Please contact us for the details.
Global Medication Adherence Devices market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing programs and initiatives organized to educate people about the significance of medical adherence. Also, the growing aging population, increasing development of healthcare expenditure, and rising usage of pharmaceuticals are expected to create significant growth opportunities for the market during the forecast period. Similarly, the growing prevalence of cardiovascular diseases is the major factor fuelling the growth of the market over the years. Additionally, the high frequency non-adherence to medication among cardiac patients has resulted in demand for medical adherence devices in the forecast period. The extensive research and development (R&D) expenditures, and expanding healthcare costs can boost the growth of the market. According to the US Centers for Disease Control and Prevention (CDC), 7 out of the 10 major causes of death in 2019 in the US were chronic illnesses. Among the various chronic diseases, heart diseases and cancer together accounted for nearly 46% of all deaths in the US in 2019.
Growing Prevalence of Cardiovascular Diseases
Most often, chronic diseases require a long therapeutic intervention by using high-dose drugs and any interruption in the medication intake can create fatal consequences which need strict medication adherence and will further boost the growth of the market during the forecast period. Cardiovascular diseases are one of the major chronic diseases across the world. Coronary heart syndrome, cerebrovascular diseases, rheumatic heart diseases, and other illnesses are among the most commonly observed cardiovascular diseases. According to the World Health Organization (WHO), 32% of all deaths across the globe i.e., 17.9 million people die due to CVD every year. Furthermore, the increasing geriatric population is susceptible to heart defects due to progressive deterioration in the structure and function of the heart, which largely contributes to the high burden of CVDs; thereby triggering the increased adoption of advanced medication adherence devices during the forecast period. Due to genetic factors, environmental factors, the oxidative stress heart diseases are increasing rapidly. The improvement of chronic diseases necessitates clinical intervention, which is accomplished by increasing the participation of patient-centric medication adherence programs, fuelling the expansion of the global medication adherence devices market.
Growing Demand for Advanced Medication Adherence
The growing demand for advanced medication adherence systems is driving the global medication adherence devices market growth in the forecast period. The healthcare ecosystem is fragmented across the globe by the presence of market players for the advanced diagnosis and treatment. The growing coordination among healthcare professionals and patients has enhanced the quality of care and its cost, as it leads to the fragmentation of healthcare information such as medical history, patient demographics, billing, diagnosis and administrative data, and this in turn is expected to boost the growth of the market over the years.
Growing Awareness about Medication Adherence
The growing awareness of medication adherence, on account of the patient-saving programs being initiated, is a major factor fuelling the growth of the medication adherence devices market in the forecast period. Medication adherence programs help in improving patient compliance. Medical adherence devices also aid pharmacists in identifying patients missing out on the timely intake of medicines. Besides, various government and non-government organizations are sponsoring events and conferences to educate patients and caregivers about medication adherence thereby driving the global medication adherence devices market growth over the years. In August 2021, Mount Sinai Health System started using a first-of-its-kind mobile application to expedite and enhance care for patients with heart attacks. The app, developed by Mount Sinai's interventional cardiologists, emergency department physicians, and the nursing team, improves communication among doctors, nurses, and the clinical command center so that patients can get more rapid care to improve outcomes.
Market Segmentation
Global Medication Adherence Devices Market can be segmented by type, medication, region and competitional landscape. Based on the type, the market can be divided into hardware centric and software centric. Based on medication, the market can be segmented into cardiovascular, central nervous system, diabetes, oncology, gastrointestinal, musculoskeletal, and others. Regionally, North America dominates the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominates the global medication adherence devices market on account of the increasing prevalence of cardiovascular diseases in the country.
Market Players
CareFusion., Proteus Digital Health., DrFirst.com, Inc., AdhereTech Inc., MedMinder., Caredose. Fruitech Ltd., PHC Holdings Corporation, MedAdvisor International Pty Ltd., McKesson Corporation. are some of the leading players operating in the Global Medication Adherence Devices Market.
Recent Developments
- In November 2018, AdhereTech Inc., announced receiving investment from Argentum Group. The company stated that with this new financing it would be increasing its pharmacy and pharmaceutical partnerships and expand into more healthcare verticals.
- September 2021: Curant Health and Humana Inc. teamed up to help in achieving better health outcomes for Humana members suffering from Chronic Obstructive Pulmonary Disease (COPD) and Chronic Heart Failure (CHF). The novel pilot program, aimed at refining medication adherence to help patients lead healthier lives and eventually help lessen health care costs, offers inclusive support for members suffering from complex health conditions and prescription medication needs.
Report Scope
In this report, Global Medication Adherence Devices market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Medication Adherence Devices Market, By Type:
- Hardware Centric
- Software Centric
Medication Adherence Devices Market, By Medication:
- Cardiovascular
- Central Nervous System
- Diabetes
- Oncology
- Gastrointestinal
- Musculoskeletal
- Others
Medication Adherence Devices Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Medication Adherence Devices Market.
Available Customizations
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Medication Adherence Devices Market Outlook
- 5.1. Market Size & Forecast
- 5.1.1. By Value
- 5.2. Market Share & Forecast
- 5.2.1. By Type (Hardware Centric v/s Software Centric)
- 5.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2022)
- 5.3. Product Map
6. North America Medication Adherence Devices Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Type (Hardware Centric v/s Software Centric)
- 6.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
- 6.2.3. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Medication Adherence Devices Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.1.1. By Value
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Type
- 6.3.1.2.2. By Medication
- 6.3.1.1. Market Size & Forecast
- 6.3.2. Canada Medication Adherence Devices Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.1.1. By Value
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Type
- 6.3.2.2.2. By Medication
- 6.3.2.1. Market Size & Forecast
- 6.3.3. Mexico Medication Adherence Devices Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.1.1. By Value
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Type
- 6.3.3.2.2. By Medication
- 6.3.3.1. Market Size & Forecast
- 6.3.1. United States Medication Adherence Devices Market Outlook
7. Europe Medication Adherence Devices Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Type (Hardware Centric v/s Software Centric)
- 7.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
- 7.2.3. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. France Medication Adherence Devices Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Type
- 7.3.1.2.2. By Medication
- 7.3.1.1. Market Size & Forecast
- 7.3.2. Germany Medication Adherence Devices Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Type
- 7.3.2.2.2. By Medication
- 7.3.2.1. Market Size & Forecast
- 7.3.3. United Kingdom Medication Adherence Devices Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Type
- 7.3.3.2.2. By Medication
- 7.3.3.1. Market Size & Forecast
- 7.3.4. Italy Medication Adherence Devices Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.1.1. By Value
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Type
- 7.3.4.2.2. By Medication
- 7.3.4.1. Market Size & Forecast
- 7.3.5. Spain Medication Adherence Devices Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.1.1. By Value
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Type
- 7.3.5.2.2. By Medication
- 7.3.5.1. Market Size & Forecast
- 7.3.1. France Medication Adherence Devices Market Outlook
8. Asia-Pacific Medication Adherence Devices Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Type (Hardware Centric v/s Software Centric)
- 8.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
- 8.2.3. By Country
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Medication Adherence Devices Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Type
- 8.3.1.2.2. By Medication
- 8.3.1.1. Market Size & Forecast
- 8.3.2. India Medication Adherence Devices Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Type
- 8.3.2.2.2. By Medication
- 8.3.2.1. Market Size & Forecast
- 8.3.3. Japan Medication Adherence Devices Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Type
- 8.3.3.2.2. By Medication
- 8.3.3.1. Market Size & Forecast
- 8.3.4. South Korea Medication Adherence Devices Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Type
- 8.3.4.2.2. By Medication
- 8.3.4.1. Market Size & Forecast
- 8.3.5. Australia Medication Adherence Devices Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Type
- 8.3.5.2.2. By Medication
- 8.3.5.1. Market Size & Forecast
- 8.3.1. China Medication Adherence Devices Market Outlook
9. South America Medication Adherence Devices Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Type (Hardware Centric v/s Software Centric)
- 9.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
- 9.2.3. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Medication Adherence Devices Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Type
- 9.3.1.2.2. By Medication
- 9.3.1.1. Market Size & Forecast
- 9.3.2. Argentina Medication Adherence Devices Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Type
- 9.3.2.2.2. By Medication
- 9.3.2.1. Market Size & Forecast
- 9.3.3. Colombia Medication Adherence Devices Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Type
- 9.3.3.2.2. By Medication
- 9.3.3.1. Market Size & Forecast
- 9.3.1. Brazil Medication Adherence Devices Market Outlook
10. Middle East and Africa Medication Adherence Devices Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Type (Hardware Centric v/s Software Centric)
- 10.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
- 10.2.3. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Medication Adherence Devices Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Type
- 10.3.1.2.2. By Medication
- 10.3.1.1. Market Size & Forecast
- 10.3.2. Saudi Arabia Medication Adherence Devices Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Type
- 10.3.2.2.2. By Medication
- 10.3.2.1. Market Size & Forecast
- 10.3.3. UAE Medication Adherence Devices Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Type
- 10.3.3.2.2. By Medication
- 10.3.3.1. Market Size & Forecast
- 10.3.1. South Africa Medication Adherence Devices Market Outlook
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
13. Global Medication Adherence Devices Market: SWOT Analysis
14. Porter's Five Forces Analysis
- 14.1. Competition in the Industry
- 14.2. Potential of New Entrants
- 14.3. Power of Suppliers
- 14.4. Power of Customers
- 14.5. Threat of Substitute Products
15. Competitive Landscape
- 15.1. Business Overview
- 15.2. Product Offerings
- 15.3. Recent Developments
- 15.4. Financials (As Reported)
- 15.5. Key Personnel
- 15.6. SWOT Analysis
- 15.6.1 CareFusion.
- 15.6.2 Proteus Digital Health.
- 15.6.3 DrFirst.com,Inc.
- 15.6.4 AdhereTech Inc.
- 15.6.5 MedMinder.
- 15.6.6 Caredose.
- 15.6.7 Fruitech Ltd.
- 15.6.8 PHC Holdings Corporation.
- 15.6.9 MedAdvisor International Pty Ltd.
- 15.6.10 McKesson Corporation.
16. Strategic Recommendations
